Grassley Wades Into Hotly Contested 340B Drug Debate With Transparency Legislation

The 340B program requires pharmaceutical companies to give steep discounts to hospitals and clinics that serve high volumes of low-income patients. Through Medicare, the federal government then reimburses the facilities for the drugs at a higher rate. A bill from Sen. Chuck Grassley (R-Iowa) would require hospitals to disclose how much they pay for drugs under the program.

from Kaiser Health News http://ift.tt/2CRIFAR